Publication | Open Access

Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity

Doxorubicin-induced CardiotoxicityInduced Pluripotent Stem CellBreast OncologyOncologyCardiac ReprogrammingBreast Cancer PatientsMedicineStem Cell ToxicologyPharmacologyPluripotent StemCancer Cell BiologyStem Cell ResearchBreast CancerCardiovascular ToxicityStem CellsCell BiologyCancer Research